- Raised $40M funding round led by Morningside Venture Investments, Nov 2021
- Raised $6M funding round, Aug 2019
About
DeepCure developed an AI platform designed to search the enormous chemical space with high accuracy. By combining the power of its deep learning algorithms, cloud computing infrastructure, and proprietary database of 1 trillion chemistries, DeepCure's platform finds drug candidates that deliver improved value to patients.
DeepCure's proprietary molecular database, MolDB, is a large medicinal chemistry database that covers over 1 trillion compounds and is expanded on demand to 1 quintillion molecules. These compounds are highly diverse and span most of the chemical space currently accessible to chemists. The trillion compounds cover more than 75% of existing medicinal chemistry compounds, including drugs and current clinical candidates in development, synthesized, or reported by medicinal chemists.
In addition, a suite of generative models can expand each selected molecule to a million analogs, expanding the search even further to 1 quintillion (10^18) molecules.
MolDB enables the discovery of candidates that don't exist in traditional screening libraries.
Funding history · 2 rounds · $46.0M total
Q&A
- What is DeepCure's primary focus?
- DeepCure focuses on AI-driven drug discovery, utilizing an AI platform to search chemical space for drug candidates.
- When was DeepCure founded?
- DeepCure was founded in September 2018.
- How much total funding has DeepCure raised?
- DeepCure has raised a total of $46,000,000.
- When did DeepCure complete its latest funding round and who were the lead investors?
- DeepCure completed a $40,000,000 funding round in November 2021, led by Morningside Venture Investments.
- What is the core technology behind DeepCure's platform?
- DeepCure's platform combines deep learning algorithms, cloud computing infrastructure, and a proprietary database of 1 trillion chemistries to find drug candidates.
- What is the name of DeepCure's proprietary molecular database?
- DeepCure's proprietary molecular database is called MolDB, which covers over 1 trillion compounds and can be expanded to 1 quintillion molecules.
- Where is DeepCure's headquarters located?
- DeepCure's headquarters is located in Boston, United States.
Team · 3
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | deepcure.com |
|---|---|
| linkedin.com/company/18557550 |
Identifiers & details
| Founded | 2018-9 |
|---|---|
| Employees (exact) | 32 |
| Offices | Boston |
Radar intelligence
Patents
| EPO | 25 |
|---|
Web history (Wayback)
| Domain | deepcure.com |
|---|
Certificate / subdomain footprint
| Subdomains | 7 |
|---|